SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-021777
Filing Date
2017-03-20
Accepted
2017-03-20 17:23:04
Documents
1
Period of Report
2017-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3113
  Complete submission text file 0001209191-17-021777.txt   4497
Mailing Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005
Business Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005 678-270-4005
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 135 U.S. HIGHWAY 206 SUITE 15 BEDMINSTER NJ 07921
Business Address
Cagle Gerald D. (Reporting) CIK: 0001589991 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 17702314